---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-017916"
form_type: "8-K"
ticker: "ATEC"
cik: "0001350653"
company_name: "Alphatec Holdings, Inc."
filed_at: "2023-05-04T23:59:59+00:00"
generated_at: "2026-06-15T21:18:49.632736+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Alphatec Q1 revenue up 54% to $109M; surgical revenue up 55%; adj EBITDA loss -$5M

## Summary
- Total revenue $109M (+54% YoY); surgical revenue +55%; EOS revenue $15M.
- GAAP gross margin 65%, non-GAAP 72%; GAAP operating loss ($40M); Adj. EBITDA loss ($5M).
- FY2023 guidance reaffirmed: revenue $450M (28% growth), surgical +30%, EOS $57M; adjuvant EBITDA break-even expected.
- Surgical volume +40%; avg revenue per procedure +11%; acquired navigation robotics platform.

## SEC filing metadata
- accession: 0000950170-23-017916
- form_type: 8-K
- ticker: ATEC
- cik: 0001350653
- company_name: Alphatec Holdings, Inc.
- filed_at: 2023-05-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1350653/000095017023017916/0000950170-23-017916-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1350653/000095017023017916/atec-20230504.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-017916
- JSON: https://secwatch.observer/filing/0000950170-23-017916.json
- Plain text: https://secwatch.observer/filing/0000950170-23-017916.txt

## Key facts
- Earnings Releases
  Alphatec Holdings, Inc. reported the quarter ended March 31, 2023 results: revenue $109 million. Guidance reaffirmed.
  - Period: the quarter ended March 31, 2023
  - Revenue: $109 million
  - Guidance: reaffirmed
  - Result: reported results
  source text: ATEC Reports First Quarter 2023 Financial Results Total revenue grew 54% to $109 million, including surgical revenue growth of 55% EOS revenue grew to $15 million Adjusted EBITDA margin improved 1,080 basis points year-over-year
  evidence_url: https://www.sec.gov/Archives/edgar/data/1350653/000095017023017916/0000950170-23-017916-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.